Phenylarsine oxide and vanadate: apparent paradox of inhibition of protein phosphotyrosine phosphatases in rat adipocytes
- 24 July 1996
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1312 (3) , 223-230
- https://doi.org/10.1016/0167-4889(96)00038-9
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- 1002 Protein Phosphatases?Annual Review of Cell Biology, 1992
- Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytesBiochemistry, 1992
- Identification of the adipocyte acid phosphatase as a PAO‐sensitive tyrosyl phosphataseProtein Science, 1992
- A cytosolic protein tyrosine kinase in rat adipocytesFEBS Letters, 1992
- Antidiabetic Action of Vanadyl in Rats Independent of in Vivo Insulin-Receptor Kinase ActivityDiabetes, 1991
- Insulin-Mimetic Effects of Vanadate: Possible Implications for Future Treatment of DiabetesDiabetes, 1990
- Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinaseBiochemistry, 1989
- The Insulin-Mimetic Effect of Vanadate Is Not Correlated with Insulin Receptor Tyrosine Kinase Activity Nor Phosphorylation in Mouse Diaphragmin VivoEndocrinology, 1989
- Phosphotyrosyl protein phosphatasesBiochemical Journal, 1989
- The Insulin-Like Effect of Vanadate on Lipolysis in Rat Adipocytes Is Not Accompanied by an Insulin-Like Effect on Tyrosine Phosphorylation*Endocrinology, 1989